138P Clinicopathological features, treatment outcomes, and prognostic factors in leiomyosarcoma: A 24-year experience from a single center
Abstract
Leiomyosarcoma (LMS) is an aggressive soft tissue sarcoma originating from smooth muscle or its mesenchymal precursor cells, accounting for approximately 10%-20% of all soft tissue sarcomas. Radiotherapy can improve local control and reduce recurrence, but its benefit on overall survival remains unclear. Chemotherapy and radiotherapy are typically used as adjuvant or combined treatment strategies. This study aims to identify prognostic factors for LMS and evaluate the efficacy of different treatment approaches to improve clinical management and provide guidance for future research.
Fields of Study & Subjects
Sarcoma Diagnosis and Treatment
Uterine Myomas and Treatments
Cardiac tumors and thrombi
Publication details
- Journal / source
- ESMO rare cancers.
- Volume
- 5
- Pages
- 100344–100344
- Publication date
- 1 March 2026
- Language
- EN